Financial Ratios

ZENOTECH LABORATORIES LTD.

NSE : NABSE : 532039ISIN CODE : INE486F01012Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE68.780.22 (+0.32 %)
PREV CLOSE ( ) 68.56
OPEN PRICE ( ) 68.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9374
TODAY'S LOW / HIGH ( )68.05 69.38
52 WK LOW / HIGH ( ) 49.681
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.903.63-0.201.77-0.51
   CEPS(Rs)3.074.780.862.560.18
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)13.4811.577.938.136.37
   Tax Rate(%)20.11-123.970.000.000.00
Margin Ratios
   Core EBITDA Margin(%)48.8047.7528.4234.51-26.99
   EBIT Margin(%)34.4530.401.4844.85-23.10
   Pre Tax Margin(%)34.1827.08-5.4141.42-24.00
   PAT Margin (%)27.3160.65-5.4141.42-24.00
   Cash Profit Margin (%)44.2279.7223.3560.068.25
Performance Ratios
   ROA(%)13.3726.45-1.4212.67-3.76
   ROE(%)15.1537.26-2.4824.35-7.73
   ROCE(%)18.3915.260.4818.32-5.95
   Asset Turnover(x)0.490.440.260.310.16
   Sales/Fixed Asset(x)0.400.350.260.400.23
   Working Capital/Sales(x)-123.98-4.46-2.95-0.88-0.50
Efficiency Ratios
   Fixed Capital/Sales(x)2.502.833.812.474.42
   Receivable days31.2038.5946.0229.5633.08
   Inventory Days0.000.611.274.7619.68
   Payable days0.000.000.003153.542423.96
Valuation Parameters
   PER(x)24.7913.860.008.320.00
   PCE(x)15.3110.5440.765.74120.64
   Price/Book(x)3.494.354.411.813.33
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)6.518.5010.334.1210.49
   EV/Core EBITDA(x)12.6717.1834.1510.57114.60
   EV/EBIT(x)18.8927.97697.379.19-45.42
   EV/CE(x)3.023.802.701.251.62
   M Cap / Sales6.778.409.523.459.95
Growth Ratio
   Net Sales Growth(%)16.0262.91-13.7499.7116.91
   Core EBITDA Growth(%)20.44166.48-33.12751.01121.69
   EBIT Growth(%)31.473244.31-97.15487.8067.99
   PAT Growth(%)-47.761925.03-111.27444.6673.61
   EPS Growth(%)-47.761925.01-111.27444.6673.61
Financial Stability Ratios
   Total Debt/Equity(x)0.000.080.430.380.52
   Current Ratio(x)0.980.470.490.160.42
   Quick Ratio(x)0.980.470.490.160.41
   Interest Cover(x)130.259.150.2113.08-25.57
   Total Debt/Mcap(x)0.000.020.100.210.16

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.